Home › US companies › Baxter International

Baxter International

BAX · NYSE · Surgical & Medical Instruments & Apparatus
Insider buys (12 months)
0
Insider sales (12 months)
0
8-K reports (12 months)
18
Tracked investors holding
1

At a glance

Baxter International reported 2025 revenue of $11.24B, up 5.7% from $10.64B in 2024. Over 4 years since 2021 ($12.15B), that is a decline of about 1.9% a year. Operating margin was -2.7%, down from 11.1% in 2021. Revenue peaked in 2021 at $12.15B. The company posted a loss in 2022 and 2025.

Baxter International filed 18 current reports (Form 8-K) in the last 12 months, most often for officer or director change (6), results of operations (4), other events (4) and material agreement (3). The latest officer or director change was reported on Aug 19, 2026. It reported a material agreement or a completed acquisition or disposal 3 times.

1 of the 20 investors tracked here held Baxter International at the last quarter end, worth $370K combined. It is the largest weight for Bridgewater Associates (0% of its portfolio). Added: Bridgewater Associates.

Annual results

2021
Revenue $12.15B
Op. $1.35B
2022
Revenue $10.06B
Op. -$2.85B
2023
Revenue $10.36B
Op. $707M
2024
Revenue $10.64B
Op. $14M
2025
Revenue $11.24B
Op. -$308M
RevenueOperating income (or net income)SEC XBRL annual filings, fiscal years mapped to calendar years
Year20212022202320242025
Net income$1.28B-$2.43B$2.66B-$649M-$957M
Diluted EPS$2.53$-4.83$5.23$-1.27$-1.87
Dividend per share$1.08$1.15$1.16$1.04$0.52

Fiscal year ends Dec 31 · incorporated in DE

Tracked investors holding (13F)

Bridgewater AssociatesAdded$370K · 0.0% · held 8 quarters

Weight is the share of each investor's portfolio, as of the quarter end.

Current reports (8-K, last 12 months)

Insider open-market trades (last 12 months)

No open-market trades in the last 12 months.

Source: SEC EDGAR. How figures are combined